The Heart and Vascular Institute at UPMC in Central Pa. recently became the first in Pennsylvania to utilize the new Edwards PASCAL Precision transcatheter valve repair system, a U.S. Food and Drug Administration (FDA) approved treatment of mitral valve regurgitation or leaky heart valve.
Mitral valve regurgitation is a common condition in which a valve connecting two chambers of the heart does not fully close, allowing blood to leak backward in the valve and impairing blood flow. The condition makes it difficult for the heart to move blood through to the rest of the heart efficiently. It may make one feel tired or out of breath, and it may cause an overall decrease in one’s quality of life.
Continue reading on UPMC